Soliton Planar Acoustic Wave Device System for Dermal Tattoo Clearing Human Trial Protocol

Inclusion Criteria: * Range of Fitzpatrick skin color scores I to III * The identical tattoo located on the arms, legs, and torso treated by Q-Switched laser and Laser + AWD during Soliton's previous 2016-001 clinical trial * Black ink only. Other ink colors may be present, but areas of black only tattoo should meet inclusion criteria * Approximately 1" x 3" tattoo with at least 30-50% of the treatment area containing black tattoo ink Exclusion Criteria: * Subject is pregnant or planning to become pregnant during the duration of the study * Medical disorder that would hinder the wound healing or immune response (no blood disorder, diabetes, inflammatory disease, etc.) * Skin disorders (skin infections or rashes, scarring, moles,birthmarks, psoriasis, etc.) * Any surgical procedure in the prior 3 months, or planned during the duration of the study * Active electronic implants such as pacemakers, defibrillators, cochlear implants, nerve/brain stimulators, etc. * Moderate to heavy tanning on and around the tattoo to be treated as determined by the Principle Investigator.